Prosecution Insights
Last updated: November 18, 2026
Application No. 18/788,198

GLITTER AND ITS USE IN COSMETIC FORMULATIONS, COATING MATERIALS AND PLASTICS

Non-Final OA §112§DOUBLEPATENT
Filed
Jul 30, 2024
Priority
Dec 14, 2018 — EU 18212680.5 +1 more
Examiner
JUSTICE, GINA CHIEUN YU
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Sigmund Lindner GmbH
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
64%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
538 granted / 967 resolved
-4.4% vs TC avg
Moderate +8% lift
Without
With
+8.4%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
38 currently pending
Career history
1021
Total Applications
across all art units

Office Action

§112 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-4 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the article" in lines 1 and 2. There is insufficient antecedent basis for this limitation in the claim. Claims 2-4 are rejected for depending on the indefinite base claim. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over clams 1-9 of U.S. Patent No. 12076425 B2, issued from US Application No. 16/714831. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of the claims are directed to a coating material, a cosmetic composition and plastic comprising a glitter comprising a foil and an aluminum layer directly coating said foil and constituting a metal-coated foil, wherein the foil comprises at least 70 wt% of natural cellulose, based on the weight of the foil, said natural cellulose consist of unaltered glucose units. See reference claims 1, 7, 6 and 8. Regarding claims 2-4, the term “coating material” in reference claim 7 is defined to include a varnish, a paint, a printing ink, an adhesive, and a sealant which can be in the form of a liquid, a paste or a powder. See col. 8, line 4-col. 9, line 25. Regarding claims 5-7, 19 and 20, the term “plastics” in reference claim 8 are also defined to include decorative and/or household object, including thermoplastics thermoset plastics. See col. 9, lines 26 – 48. Regarding claim 8-11, the “coating material” is defined to include a material in liquid, paste or powder which is applied to the full area or part of objects and is able to form coat through chemical or physical processes. See col. 9, lines 2-5. Regarding claims 12-18, the term “cosmetic product” in reference claim 6 is defined to include a varnish, a paste, a salve, a cream, an emulsion, etc., where the glitter may be in present in an amount ranging from 0.01-75 wt % or up to 100 wt % in case of powder. See col. 8, lines 25-63. Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to GINA JUSTICE whose telephone number is (571)272-8605. The examiner can normally be reached M-F 9:00 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, BETHANY BARHAM can be reached at 571-272-6175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /GINA C JUSTICE/Primary Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Jul 30, 2024
Application Filed
Aug 20, 2026
Non-Final Rejection mailed — §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797312
BREAKABLE GALENIC CAPSULE
4y 3m to grant Granted Nov 17, 2026
Patent 12778140
PLANT STOMATA OPENING PROMOTING AGENT
4y 4m to grant Granted Nov 03, 2026
Patent 12757896
Use of polyglycerol esters as carriers for microbiological active ingredients
4y 11m to grant Granted Oct 13, 2026
Patent 12758604
PHARMACEUTICAL COMPOSITION FOR TREATING MYOCARDIAL ISCHEMIA AND PREPARATION METHOD THEREFOR
3y 5m to grant Granted Oct 13, 2026
Patent 12757920
HYDROGEN-GENERATING COMPOSITION FOR DIETARY AND AGRICULTURAL APPLICATIONS
3y 9m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
64%
With Interview (+8.4%)
Low
PTA Risk
Based on 967 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month